Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis

Pathogens and Disease

Volumn 70, Issue 3, 2014, Pages 359-369

  Ackart, David F ^a   Hascall Dove, Laurel ^a   Caceres, Silvia M ^b   Kirk, Natalie M ^a   Podell, Brendan K ^a   Melander, Christian ^c   Orme, Ian M ^a   Leid, Jeff G ^d   Nick, Jerry A ^b   Basaraba, Randall J ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d W L GORE AND ASSOCIATES   (United States)

Author keywords

Biofilm; Drug resistant; Drug tolerant; Microbial communities; Mycobacterium tuberculosis

Indexed keywords

DEOXYRIBONUCLEASE I; ISONIAZID; POLYSORBATE 80; PYRAZINAMIDE; RIFAMPICIN; CULTURE MEDIUM; POLYSORBATE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BIOFILM; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MICROBIAL COMMUNITY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; CULTURE MEDIUM; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY;

ANTITUBERCULAR AGENTS; BIOFILMS; CULTURE MEDIA; DEOXYRIBONUCLEASE I; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POLYSORBATES; RIFAMPIN;

EID: 84912000474     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12144     Document Type: Article

References (71)

1. Abadie V, Badell E, Douillard P et al. (2005) Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. Blood 106: 1843-1850.
2. Ahmad Z, Klinkenberg LG, Pinn ML et al. (2009) Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig. J Infect Dis 200: 1136-1143.
3. Armitige LY, Jagannath C, Wanger AR & Norris SJ (2000) Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages. Infect Immun 68: 767-778.
4. Bakker EM, Volpi S, Salonini E et al. (2011) Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation. Eur Respir J 38: 1328-1335.
5. Barclay WR, Ebert RH, Manthei RW & Roth LJ (1953) Distribution of C14 labeled isoniazid in sensitive and resistant tubercle bacilli and in infected and uninfected tissues in tuberculous patients. Trans Annu Meet Natl Tuberc Assoc 49: 192-195.
6. Basaraba RJ (2008) Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies. Tuberculosis (Edinb) 88(suppl. 1): S35-S47.
7. Brinkmann V, Reichard U, Goosmann C et al. (2004) Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535.
8. Canetti G (1955) The Tubercle Bacillus in the Pulmonary Lesion of Man; Histobacteriology and its Bearing on the Therapy of Pulmonary Tuberculosis. Springer Publishing Company Inc., New York, NY.
9. Chen JM, Ren H, Shaw JE et al. (2008) Lsr2 of Mycobacterium tuberculosis is a DNA-bridging protein. Nucleic Acids Res 36: 2123-2135.
10. Deb C, Lee CM, Dubey VS et al. (2009) A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS One 4: e6077.
11. Dubos RJ (1946) Effect of long chain fatty acids on bacterial growth. Proc Soc Exp Biol Med 63: 56-58.
12. Dubos RJ & Davis BD (1946) Factors affecting the growth of tubercle bacilli in liquid media. J Exp Med 83: 409-423.
13. Erdemli SB, Gupta R, Bishai WR, Lamichhane G, Amzel LM & Bianchet MA (2012) Targeting the cell wall of Mycobacterium tuberculosis: structure and mechanism of L, D-transpeptidase 2. Structure 20: 2103-2115.
14. Fahy JV, Steiger DJ, Liu J, Basbaum CB, FinkbeinerWE & Boushey HA (1993) Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 147: 1132-1137.
15. Fenhalls G, Stevens-Muller L, Warren R, Carroll N, Bezuidenhout J, Van Helden P & Bardin P (2002) Localisation of mycobacterial DNA and mRNA in human tuberculous granulomas. J Microbiol Methods 51: 197-208.
16. Franzblau SG, Witzig RS, McLaughlin JC et al. (1998) Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol 36: 362-366.
17. Franzblau SG, DeGroote MA, Cho SH et al. (2012) Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis. Tuberculosis (Edinb) 92: 453-488.
18. Goodman SD, Obergfell KP, Jurcisek JA et al. (2011) Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid-associated proteins. Mucosal Immunol 4: 625-637.
19. Gordon BR, Li Y, Wang L et al. (2010) Lsr2 is a nucleoid-associated protein that targets AT-rich sequences and virulence genes in Mycobacterium tuberculosis.PNatlAcadSciUSA107:5154-5159.
20. Green C, Huggett JF, Talbot E, Mwaba P, Reither K & Zumla AI (2009) Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods. Lancet Infect Dis 9: 505-511.
21. Gruppo V, Johnson CM, Marietta KS et al. (2006) Rapid microbiologic and pharmacologic evaluation of experimental compounds against Mycobacterium tuberculosis. Antimicrob Agents Chemother 50: 1245-1250.
22. Harper J, Skerry C, Davis SL et al. (2012) Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions. J Infect Dis 205: 595-602.
23. Heng Y, Seah PG, Siew JY et al. (2011) Mycobacterium tuberculosis infection induces hypoxic lung lesions in the rat. Tuberculosis (Edinb) 91: 339-341.
24. Hoff DR, Ryan GJ, Driver ER, Ssemakulu CC, De Groote MA, Basaraba RJ & Lenaerts AJ (2011) Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment. PLoS One 6: e17550.
25. Kaplan JB (2009) Therapeutic potential of biofilm-dispersing enzymes. Int J Artif Organs 32: 545-554.
26. Kapoor N, Pawar S, Sirakova TD, Deb C, Warren WL & Kolattukudy PE (2013) Human granuloma in vitro model, for TB dormancy and resuscitation. PLoS One 8: e53657.
27. Leistikow RL, Morton RA, Bartek IL, Frimpong I, Wagner K & Voskuil MI (2010) The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J Bacteriol 192: 1662-1670.
28. Lenaerts AJ, Hoff D, Aly S et al. (2007) Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910. Antimicrob Agents Chemother 51: 3338-3345.
29. Liu J & Gordon BR (2012) Targeting the global regulator Lsr2 as a novel approach for anti-tuberculosis drug development. Expert Rev Anti Infect Ther 10: 1049-1053.
30. Ma AC & Kubes P (2008) Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. J Thromb Haemost 6: 415- 420.
31. Mann EE, Rice KC, Boles BR et al. (2009) Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLoS One 4: e5822.
32. Manthei RW, Roth LJ, Barclay WR & Ebert RH (1954) The distribution of C14 labeled isoniazid in normal and infected guinea pigs. Arch Int Pharmacodyn Ther 98: 183-192.
33. Mitchison D & Davies G (2012) The chemotherapy of tuberculosis: past, present and future. Int J Tuberc Lung Dis 16: 724-732.
34. Nozawa RT & Yokota T (1983) Rapid drug susceptibility testing of mycobacteria in tissue culture medium. Antimicrob Agents Chemother 24: 268-272.
35. Obregon-Henao A, Duque-Correa MA, Rojas M, Garcia LF, Brennan PJ, Ortiz BL & Belisle JT (2012) Stable extracellular RNA fragments of Mycobacterium tuberculosis induce early apoptosis in human monocytes via a caspase-8 dependent mechanism. PLoS One 7: e29970.
36. Ojha AK, Baughn AD, Sambandan D et al. (2008) Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol 69: 164-174.
37. Ordway DJ, Shanley CA, Caraway ML et al. (2010) Evaluation of standard chemotherapy in the guinea pig model of tuberculosis. Antimicrob Agents Chemother 54: 1820-1833.
38. Pang JM, Layre E, Sweet L, Sherrid A, Moody DB, Ojha A & Sherman DR (2012) The polyketide Pks1 contributes to biofilm formation in Mycobacterium tuberculosis. J Bacteriol 194: 715-721.
39. Parker SK, Curtin KM & Vasil ML (2007) Purification and characterization of mycobacterial phospholipase A: an activity associated with mycobacterial cutinase. J Bacteriol 189: 4153-4160.
40. Parks QM, Young RL, Poch KR, Malcolm KC, Vasil ML & Nick JA (2009) Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy. J Med Microbiol 58: 492-502.
41. Patel K, Jhamb SS & Singh PP (2011) Models of latent tuberculosis: their salient features, limitations, and development. J Lab Physicians 3: 75-79.
42. Piddock LJ, Williams KJ & Ricci V (2000) Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis. J Antimicrob Chemother 45: 159-165.
43. Prabhakar S, Mishra A, Singhal A, Katoch VM, Thakral SS, Tyagi JS & Prasad HK (2004) Use of the hupB gene encoding a histone-like protein of Mycobacterium tuberculosis as a target for detection and differentiation of M. tuberculosis and M. bovis. J Clin Microbiol 42: 2724-2732.
44. Pressler T (2008) Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis. Biologics 2: 611-617.
45. Prideaux B, Dartois V, Staab D et al. (2011) High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions. Anal Chem 83: 2112-2118.
46. Puchelle E, Zahm JM, de Bentzmann S, Grosskopf C, Shak S, Mougel D & Polu JM (1996) Effects of rhDNase on purulent airway secretions in chronic bronchitis. Eur Respir J 9: 765-769.
47. Ramasubbu N, Thomas LM, Ragunath C & Kaplan JB (2005) Structural analysis of dispersin B, a biofilm-releasing glycoside hydrolase from the periodontopathogen Actinobacillus actinomycetemcomitans. J Mol Biol 349: 475-486.
48. Ramos-Kichik V, Mondragon-Flores R, Mondragon-Castelan M et al. (2009) Neutrophil extracellular traps are induced by Mycobacterium tuberculosis. Tuberculosis (Edinb) 89: 29-37.
49. Ramsugit S, Guma S, Pillay B, Jain P, Larsen MH, Danaviah S & Pillay M (2013) Pili contribute to biofilm formation in vitro in Mycobacterium tuberculosis. Antonie Van Leeuwenhoek 104: 725-735.
50. Ryan GJ, Hoff DR, Driver ER et al. (2010) Multiple M. tuberculosis phenotypes in mouse and guinea pig lung tissue revealed by a dual-staining approach. PLoS One 5: e11108.
51. Sambandan D, Dao DN, Weinrick BC et al. (2013) Keto-mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive Mycobacterium tuberculosis. MBio 4: e00222-00213.
52. Sani M, Houben EN, Geurtsen J et al. (2010) Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins. PLoS Pathog 6: e1000794.
53. Sarathy J, Dartois V, Dick T & Gengenbacher M (2013) Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother 57: 1648-1653.
54. Sattler TH & Youmans GP (1948) The effect of "Tween 80", bovine albumin, glycerol, and glucose on the growth of Mycobacterium tuberculosis var. hominis (H37Rv). J Bacteriol 56: 235-243.
55. Speer A, Shrestha TB, Bossmann SH et al. (2013) Copper-boosting compounds: a novel concept for antimycobacterial drug discovery. Antimicrob Agents Chemother 57: 1089-1091.
56. Stoops JK, Arora R, Armitage L et al. (2010) Certain surfactants show promise in the therapy of pulmonary tuberculosis. In Vivo 24: 687-694.
57. Tetz GV, Artemenko NK & Tetz VV (2008) Effect of DNase and antibiotics on biofilm characteristics. Antimicrob Agents Chemother 53: 1204-1209.
58. Tsai MC, Chakravarty S, Zhu G et al. (2006) Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol 8: 218-232.
59. Ulrichs T & Kaufmann SH (2006) New insights into the function of granulomas in human tuberculosis. J Pathol 208: 261-269.
60. van Staden M, van der Ryst E, Attwood EM, Hendricks ML, Joubert G & Weich DJ (1998) Detection of Mycobacterium tuberculosis in serum samples using the polymerase chain reaction. J Infect 36: 273-277.
61. Via LE, Lin PL, Ray SM et al. (2008) Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 76: 2333-2340.
62. Walker TS, Tomlin KL, Worthen GS et al. (2005) Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun 73: 3693-3701.
63. Wartha F, Beiter K, Normark S & Henriques-Normark B (2007) Neutrophil extracellular traps: casting the NET over pathogenesis. Curr Opin Microbiol 10: 52-56.
64. Wayne LG & Hayes LG (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64: 2062-2069.
65. Wayne LG & Sohaskey CD (2001) Nonreplicating persistence of Mycobacterium tuberculosis. Annu Rev Microbiol 55: 139-163.
66. Whitchurch CB, Tolker-Nielsen T, Ragas PC & Mattick JS (2002) Extracellular DNA required for bacterial biofilm formation. Science 295: 1487.
67. Wilson GS & Schwabacher H (1935) The relationship between moist weight and numbers of total and viable organisms in cultures of tubercle bacilli. Tubercle 17: 161.
68. Wong KW & Jacobs WR Jr (2013) Mycobacterium tuberculosis exploits human interferon gamma to stimulate macrophage extracellular trap formation and necrosis. J Infect Dis 208: 109- 119.
69. Yang L, Barken KB, Skindersoe ME, Christensen AB, Givskov M & Tolker-Nielsen T (2007) Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa. Microbiology 153: 1318-1328.
70. YeruvaVC,Duggirala S, Lakshmi V,KolarichD, Altmann F & Sritharan M (2006) Identification and characterization of a major cell wall-associated iron-regulated envelope protein (Irep-28) in Mycobacterium tuberculosis. Clin Vaccine Immunol 13: 1137-1142.
71. Zhang M, Gong J, Lin Y & Barnes PF (1998) Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun 66: 794-799.